Gracia-Francis M, Juárez-Nieto O

Language: Spanish
References: 14
Page: 82-85
PDF size: 133.37 Kb.

ABSTRACT

The objective of this study is to show the experience of the use of glycine gel with calcium as a hemostatic method in patients with previous epistaxis. Material and methods: Prospective, longitudinal study, where the purpose of the study was analytical and the control of the assignment of the factors of study was experimental, where the efficacy of glycine gel with calcium will be identified as a non-invasive haemostatic method in patients with previous epistaxis attended by the Otorhinolaryngology, Head and Neck Service, of the Hospital Juárez de México, starting in February 2017 to February 2018. Statistical analysis: descriptive statistics. Results: A population of 75 patients was used. Of the patients interviewed, 33 were female and 42 were male. The average age of the patients was 45.5 years, where the maximum was 84 years and the minimum was 8 years, 43.7 years for women and 47.8 years for men. A total of 39 patients suffered from at least one chronic degenerative disease, 25 cases of systemic arterial hypertension, 14 cases of diabetes mellitus and 14 patients presenting with both conditions. The average number of applications was about 1.02 per patient, with 10 cases in which treatment failed. Conclusions: With respect to the efficacy of the product, a total satisfactory response of 82% was obtained, so the use of this product as a non-invasive treatment in previous epistaxis is recommended.

REFERENCES

1. McLarnon CM, Carrie S. Epistaxis. Surgery 2015; 33(12): 587-92.

2. Encyclopédie Médico-Chirurgicale – E – 20-310-A-10 Epistaxis 2000, Editions Scientifiques et Médicales Elsevier SAS, París.

3. Viehweg TL, Roberson JB, Hudson JW. Epistaxis: diagnosis and treatment. J Oral Maxillofac Surg 2006; 64(3): 511-8.

4. Myers N, Snyderman CH, Carrau RL. Operative otolaryngology: head and neck surgery. Volume 2. Chapter 2: Epistaxis. Pittsburgh, Pennsylvania: Elsevier; 2008.

5. Morgan DJ, Kellerman R. Epistaxis: evaluation and treatment. Prim Care 2014; 41(1): 63-73.

6. Bluestone C, Rosenfeld R. Surgical atlas of pediatric otolaryngology. Chapter 10: Epistaxis. Brooklyn, New York: BC Decker; 2002.

7. Rodríguez-Perales MA. Otorrinolaringología y cirugía de cabeza y cuello. México, D.F.: McGraw-Hill Interamericana Editores, S.A. DE C.V.; 2009.

8. Kotecha B, Fowler S, Harkness P, et al. Management of epistaxis: a national survey. Ann R Coll Surg Engl 1996; 78: 444-6.

9. Kourelis K, Shikani AH. Effectiveness of chitosan-based packing in 35 patients with recalcitrant epistaxis en the contex of cuagulopathy. Clinical Otolaryngology 2012; 37: 305-30.

10. Carter G, Goss A. Tranexamic acid mouthwash-a prospective randomized study of a 2-day regimen vs 5-day regimen to prevent postoperative bleeding in anticoagulated patients requiring dental extractions. Int J Oral Maxillofac Surg 2003; 32(5): 504-7.

11. Samudrala S. Topical hemostatic agents in surgery: a surgeon’s perspective. AORN J 2008; 88(3): S2-11.

12. Guía de Práctica Clínica Diagnóstico y Tratamiento de Epistaxis Evidencias y Recomendaciones Número de Registro: IMSS18009.

13. Côté D, Barber B, Diamond C, Wright E. FloSeal hemostatic matrix in persistent epistaxis: prospective clinical trial. Journal of Otolaryngology-Head & Neck Surgery 2010; 39(3): 304-8.

14. Glynn F, Amin M, Sheahan P, Mc Shane D. Prospective double blind randomized clinical trial comparing 75% versus 95% silver nitrate cauterization in the management of idiopathic childhood epistaxis. Int J Pediatr Otorhinolaryngol 2011; 75(1): 81-4.